Publications by authors named "Adam D Shilling"

Claim this Profile
D
Desvenlafaxine and venlafaxine exert minimal in vitro inhibition of human cytochrome P450 and P-glycoprotein activities.
Aram Oganesian, Adam D Shilling, Ruth Young-Sciame, Judy Tran, Adiba Watanyar

Psychopharmacol Bull· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1/2 inhibitor, in humans.
Adam D Shilling, Frank M Nedza, Thomas Emm, Sharon Diamond, Edward McKeever

Drug Metab Dispos· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical characterization of BRL 44408: antidepressant- and analgesic-like activity through selective alpha2A-adrenoceptor antagonism.
Jason M Dwyer, Brian J Platt, Stacey J Sukoff Rizzo, Claudine M Pulicicchio, Caitlin Wantuch, Adam D Shilling

Int J Neuropsychopharmacol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.
Rayomand J Unwalla, Jason B Cross, Sumeet Salaniwal, Adam D Shilling, Louis Leung

J Comput Aided Mol Des· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, potency, and in vivo evaluation of 2-piperazin-1-ylquinoline analogues as dual serotonin reuptake inhibitors and serotonin 5-HT1A receptor antagonists.
Dahui Zhou, Gary P Stack, Jennifer Lo, Amedeo A Failli, Deborah A Evrard, Adam D Shilling

J Med Chem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis